Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Diovan Enjoys Steady Growth, Sales of \60 Bil. in 2003
January 19, 2004
- REGULATORY NEWS IN BRIEF
January 19, 2004
- IMS Japan Aims to Become a Services-based Company: President Saeki
January 12, 2004
- ON THE MOVE
January 12, 2004
- Time to New Drug Approval Down Sharply Since Mid-90s: OPIR
January 12, 2004
- Test Kit to Be Developed to Predict Effects of Morphine
January 12, 2004
- BUSINESS NEWS IN BRIEF
January 12, 2004
- RA Patients Criticized as Selfish, Lazy: Wyeth Survey
January 12, 2004
- BULLETIN
January 12, 2004
- Pharmacokinetic Frequency Analysis Database Jointly Developed by PSC, JBIC
January 12, 2004
- FJPWA Petitions Korosho Regarding Joint Purchasing
January 12, 2004
- DIAGNOSTIC NEWS IN BRIEF
January 12, 2004
- Council Supports Inspection, Payment of Dispensing Bills by Insurers
January 12, 2004
- MEDICAL DEVICE NEWS IN BRIEF
January 12, 2004
- Monkasho Facing 4.5% Budget Cut in FY2004
January 12, 2004
- JACDS to Create Certification System for Kampo Advisors
January 12, 2004
- NEW PRODUCTS
January 12, 2004
- Semi-annual Business Results
January 12, 2004
- Korosho Starts General Review of Post-Marketing Safety Policies
January 12, 2004
- Funding for Disease Measures Up Slightly in Korosho's FY2004 Budget
January 12, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…